These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24829151)

  • 41. LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene.
    Ambrosio S; Amente S; Saccà CD; Capasso M; Calogero RA; Lania L; Majello B
    Oncotarget; 2017 Jan; 8(3):3854-3869. PubMed ID: 27894074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
    Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy.
    Fang BA; Kovačević Ž; Park KC; Kalinowski DS; Jansson PJ; Lane DJ; Sahni S; Richardson DR
    Biochim Biophys Acta; 2014 Jan; 1845(1):1-19. PubMed ID: 24269900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.
    Coluccia AM; Benati D; Dekhil H; De Filippo A; Lan C; Gambacorti-Passerini C
    Cancer Res; 2006 Feb; 66(4):2279-86. PubMed ID: 16489032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-myc downstream regulated 1 gene and its place in the cellular machinery.
    Kitowska A; Pawełczyk T
    Acta Biochim Pol; 2010; 57(1):15-21. PubMed ID: 20300662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequently rearranged in advanced T‑cell lymphomas‑1 demonstrates oncogenic properties in prostate cancer.
    Zhang W; Xiong H; Zou Y; Xu S; Quan L; Yuan X; Xu N; Wang Y
    Mol Med Rep; 2016 Oct; 14(4):3551-8. PubMed ID: 27599661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
    Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
    Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein kinase A antagonist inhibits β-catenin nuclear translocation, c-Myc and COX-2 expression and tumor promotion in Apc(Min/+) mice.
    Brudvik KW; Paulsen JE; Aandahl EM; Roald B; Taskén K
    Mol Cancer; 2011 Dec; 10():149. PubMed ID: 22168384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The p21-activated kinase 4-Slug transcription factor axis promotes epithelial-mesenchymal transition and worsens prognosis in prostate cancer.
    Park JJ; Park MH; Oh EH; Soung NK; Lee SJ; Jung JK; Lee OJ; Yun SJ; Kim WJ; Shin EY; Kim EG
    Oncogene; 2018 Sep; 37(38):5147-5159. PubMed ID: 29849120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism.
    Liu W; Zhang B; Hu Q; Qin Y; Xu W; Shi S; Liang C; Meng Q; Xiang J; Liang D; Ji S; Liu J; Hu P; Liu L; Liu C; Long J; Ni Q; Yu X; Xu J
    Int J Oncol; 2017 May; 50(5):1792-1800. PubMed ID: 28350132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Par-4 dependent modulation of cellular β-catenin by medicinal plant natural product derivative 3-azido Withaferin A.
    Amin H; Nayak D; Ur Rasool R; Chakraborty S; Kumar A; Yousuf K; Sharma PR; Ahmed Z; Sharma N; Magotra A; Mukherjee D; Kumar LD; Goswami A
    Mol Carcinog; 2016 May; 55(5):864-81. PubMed ID: 25969134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21.
    Zhang S; Yu C; Yang X; Hong H; Lu J; Hu W; Hao X; Li S; Aikemu B; Yang G; He Z; Zhang L; Xue P; Cai Z; Ma J; Zang L; Feng B; Yuan F; Sun J; Zheng M
    J Exp Clin Cancer Res; 2019 Dec; 38(1):490. PubMed ID: 31831018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-myc downstream regulated gene 1 modulates Wnt-β-catenin signalling and pleiotropically suppresses metastasis.
    Liu W; Xing F; Iiizumi-Gairani M; Okuda H; Watabe M; Pai SK; Pandey PR; Hirota S; Kobayashi A; Mo YY; Fukuda K; Li Y; Watabe K
    EMBO Mol Med; 2012 Feb; 4(2):93-108. PubMed ID: 22246988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. INKA2, a novel p53 target that interacts with the serine/threonine kinase PAK4.
    Liu YY; Tanikawa C; Ueda K; Matsuda K
    Int J Oncol; 2019 Jun; 54(6):1907-1920. PubMed ID: 31081062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PAK4 Methylation by SETD6 Promotes the Activation of the Wnt/β-Catenin Pathway.
    Vershinin Z; Feldman M; Chen A; Levy D
    J Biol Chem; 2016 Mar; 291(13):6786-95. PubMed ID: 26841865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Knockdown of NDRG1 promote epithelial-mesenchymal transition of colorectal cancer via NF-κB signaling.
    Ma J; Gao Q; Zeng S; Shen H
    J Surg Oncol; 2016 Sep; 114(4):520-7. PubMed ID: 27338835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SUMO modification regulates the protein stability of NDRG1.
    Lee JE; Kim JH
    Biochem Biophys Res Commun; 2015 Mar; 459(1):161-5. PubMed ID: 25712528
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FRAT1, a substrate-specific regulator of glycogen synthase kinase-3 activity, is a cellular substrate of protein kinase A.
    Hagen T; Cross DA; Culbert AA; West A; Frame S; Morrice N; Reith AD
    J Biol Chem; 2006 Nov; 281(46):35021-9. PubMed ID: 16982607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glial cell line-derived neurotrophic factor promotes β-catenin phosphorylation and nuclear translocation in glioma cells.
    Qu D; Zhang C; Liu Y; Wang L; Wang J; Xiong Y; Gao D
    J Neurosurg Sci; 2015 Dec; 59(4):429-35. PubMed ID: 25423132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NDRG2 and PRA1 interact and synergistically inhibit T-cell factor/β-catenin signaling.
    Kim JT; Kim JW; Kang YH; Kim KD; Lee SJ; Choi SC; Kim KS; Chae SK; Kim JW; Lim JS; Lee HG
    FEBS Lett; 2012 Nov; 586(22):3962-8. PubMed ID: 23068607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.